Search

everythinglearnresearchcommunity

for

Search:↓

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.

High testosterone increases heart disease risk in women with PCOS.

The case shows skin changes can indicate deeper health issues like insulin resistance, which are challenging to manage.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

A woman's male-like physical changes were caused by two rare ovarian conditions.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Skin symptoms can indicate endocrine disorders and have various treatments.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.